Talecris Biotherapeutics Holdings Corp.·4

Sep 3, 5:30 PM ET

Nogales Bruce 4

4 · Talecris Biotherapeutics Holdings Corp. · Filed Sep 3, 2010

Insider Transaction Report

Form 4
Period: 2010-09-01
Nogales Bruce
Sr. VP & GM, Plasma Resources
Transactions
  • Sale

    Common Stock

    2010-09-01$21.99/sh40,000$879,6365,921 total
Footnotes (3)
  • [F1]The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2010.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.9625 to $22.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  • [F3]The number of shares reported consists of restricted share units representing the right to receive 5,921 shares of the Issuers common stock that will vest in three equal annual installments beginning April 1, 2011, as detailed in a restricted share unit award agreement by and between the Issuer and the Reporting Person, dated as of September 30, 2009.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT